Patents expiring in 2028

US 7419956

Isolated physiologically active peptide and use thereof

Takeda Pharmaceutical Company Limited · Granted Tue Sep 02 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 28 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7419991

3-[5-(2-fluoro-phenyl)-[1,2,4]oxadiazol-3-yl]-benzoic acid, compositions, and methods for the use thereof

PTC THERAPEUTICS, INC. · Granted Tue Sep 02 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 28 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7419957

Peptides of melanoma antigen and their use in diagnostic, prophylactic and therapeutic methods

The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Tue Sep 02 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 28 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7423142

Compositions and methods for inhibiting expression of anti-apoptotic genes

Alnylam Pharmaceuticals, Inc. · Granted Tue Sep 09 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 04 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7423049

Inhibitors of p38

Vertex Pharmaceuticals Incorporated · Granted Tue Sep 09 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 04 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7422755

Antimultiorganism glycoconjugate vaccine

The United States of America, as represented by the Department of Health and Human Services · Granted Tue Sep 09 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 04 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7422738

Combined cancer treatment methods using antibodies to aminophospholipids

The Board of Regents of the University of Texas System · Granted Tue Sep 09 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 04 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7423159

Agent for preventing or treating neuropathy

Takeda Pharmaceutical Company Limited · Granted Tue Sep 09 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 04 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7423066

Methods, compounds, and compositions for reducing body fat and modulating fatty acid metabolism

The Regents of the University of California · Granted Tue Sep 09 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 04 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7423015

Antihelminthic drugs as a treatment for hyperproliferative diseases

The Board of Regents of the University of Texas System · Granted Tue Sep 09 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 04 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7423043

4-Piperidin-1-yl-7H-pyrrolo[2,3-d]pyrimidine compounds

LEXICON PHARMACEUTICALS, INC. · Granted Tue Sep 09 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 04 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7422867

Methods of identifying compounds that modulate IL-4 receptor mediated IgE synthesis utilizing a CLLD8 protein

Rigel Pharmaceuticals, Inc. · Granted Tue Sep 09 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 04 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7422900

System and method for forming a connective tissue construct

THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Tue Sep 09 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 04 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7423118

IAPS associated cell cycle proteins, compositions and methods of use

Rigel Pharmaceuticals, Inc. · Granted Tue Sep 09 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 04 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7425449

Site specific Listeria integration vectors and methods for using the same

The Regents of the University of California · Granted Tue Sep 16 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 11 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7425329

Methods for treating bone cancer pain by administering a nerve growth factor antagonist

Regents of the University of Minnesota · Granted Tue Sep 16 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 11 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7425218

Nitric oxide-releasing medical devices

The United States of America, as represented by the Department of Health and Human Services · Granted Tue Sep 16 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 11 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7425644

Method of purifying pravastatin

TEVA Gyógyszergyár Zártkörüen Müködö Részvénytárasaság · Granted Tue Sep 16 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 11 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7425611

Immunogenic HIV-1 multi-clade, multivalent constructs and methods of their use

The United States of America as represented by the Secretary of the Department of Health and Human Services, Centers for Disease Control and Prevention · Granted Tue Sep 16 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 11 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7427671

Compositions of alpha platelet derived growth factor receptor nucleic acid and protein and method of making

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue Sep 23 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 18 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7427639

β2-adrenergic receptor agonists

Theravance, Inc. · Granted Tue Sep 23 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 18 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7427602

Sustained DNA delivery from structural matrices

THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Tue Sep 23 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 18 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7427590

Neurothrophic components of the ADNF I complex

The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Tue Sep 23 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 18 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7427598

Post-natal administration of activity-dependent neurotrophic factor-derived polypeptides for enhancing learning and memory

The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Tue Sep 23 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 18 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7427496

Anti-cancer compounds

The Regents of the University of Colorado · Granted Tue Sep 23 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 18 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7427408

Quorum sensing and biofilm formation

The Regents of the University of California · Granted Tue Sep 23 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 18 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

CA 2626142

SOLUTIONS AQUEUSES STABILISEES DE COMPOSES D'ERGOLINE

AXXONIS PHARMA AG [DE] · Granted Tue Sep 23 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 18 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7427681

Pyrazole compounds useful as protein kinase inhibitors

Vertex Pharmaceuticals Incorporated · Granted Tue Sep 23 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 18 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7427630

Condensed N-heterocyclic compounds and their use as CRF receptor antagonists

Neurocrine Biosciences, Inc. · Granted Tue Sep 23 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 18 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7427394

Biodegradable poly(β-amino esters) and uses thereof

The United States of America as represented by the Secretary of the Army · Granted Tue Sep 23 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 18 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7427389

Diagnostic agents for positron emission imaging using radiolabeled halogenated xanthenes

Provectus Pharmatech, Inc. · Granted Tue Sep 23 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 18 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7429457

Id-1 and Id-2 genes and products as markers of epithelial cancer

The Regents of the University of California · Granted Tue Sep 30 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 25 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7429559

Controlled release composition and method of producing the same

Takeda Pharmaceutical Company Limited · Granted Tue Sep 30 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 25 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7429562

Cyclosporin analog formulations

Isotechnika, Inc. · Granted Tue Sep 30 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 25 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7429596

1H-pyrrolo [2,3-D] pyrimidine derivatives and methods of use thereof

The Regents of the University of California · Granted Tue Sep 30 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 25 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7429374

Process for the measurement of the potency of glatiramer acetate

TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Tue Sep 30 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 25 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7429387

Use of botulinum toxin therapy for treatment of recalcitrant voiding dysfunction

The Regents of the University of Colorado · Granted Tue Sep 30 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 25 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7429571

Therapeutic furopyrimidines and thienopyrimidines

BioCryst Pharmaceuticals, Inc. · Granted Tue Sep 30 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 25 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7429238

Systems and methods for the generation of crystalline polymorphs

THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Tue Sep 30 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 25 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7429616

Synthesis and complete stereochemical assignment of psymberin/irciniastatin for use as antitumor compounds

The Board of Regents of the University of Texas System · Granted Tue Sep 30 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 25 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7429485

Method of producing infectious reovirus

ONCOLYTICS BIOTECH INC. · Granted Tue Sep 30 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 25 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

US 2008241252

METHODS AND COMPOSITIONS FOR INTRAOCULAR ADMINISTRATION TO TREAT OCULAR CONDITIONS

ALLERGAN INC [US] · Granted Thu Oct 02 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Wed Sep 27 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

CA 2682039

PREPARATIONS COSMETIQUES VISANT A REDUIRE LA CELLULITE DISGRACIEUSE

MENARINI FARMA IND [IT] · Granted Thu Oct 02 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Wed Sep 27 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7431932

Reovirus clearance of ras-mediated neoplastic cells from mixed cellular compositions

ONCOLYTICS BIOTECH INC. · Granted Tue Oct 07 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 02 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7432067

Methods of detection of MATER protein autoantibodies

The United States of America as Represented by The Secretary of the Department of Health and Human Services National Institutes of Health Office of Technology Transfer · Granted Tue Oct 07 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 02 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7432093

Soluble, functional apoptotic protease-activating factor 1 fragments

THE TRUSTEES OF PRINCETON UNIVERSITY · Granted Tue Oct 07 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 02 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7432292

Sulfhydantoins as phosphate isosteres

Vertex Pharmaceuticals Incorporated · Granted Tue Oct 07 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 02 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7432300

Gossypol co-crystals and the use thereof

THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Tue Oct 07 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 02 2028 00:00:00 GMT+0000 (Coordinated Universal Time)